Bed Bath & Beyond Inc. (NASDAQ: BBBY) reported its
1Q results, with the EPS missing expectations, driven by worse comps.
Morgan Stanley’s Simeon Gutman maintains an Underweight rating on the company, with a price target of $40.
Weak 1Q
Gutman mentioned this was the company’s weakest gross profit dollar performance in three years, driven by comps and a dilutive
shift to e-commerce.
The analyst pointed that that Bed Bath & Beyond’s 1Q results highlighted three investment issues.
3 Issues
First, Gutman believes the channel shift from store to online continues to pressure margins, with gross margins having declined
75 bps and EBIT margin contracting 220 bps to become the lowest Q1 EBIT margin since 2008.
“To be fair, Q1 is the smallest seasonal quarter, 2016 was slated to be an investment year and the removal of quarterly guidance
may have led to a wider margin/EPS miss vs. consensus relative to the company’s internal plans,” the analyst explained.
Related Link: Still
Unclear When Bed Bath & Beyond's Initiatives Will Bear Fruit
Although management indicated that the Q1 results were “directionally in-line” with their plans, the channel shift is likely to
impact both EBIT margin and ROIC.
“Second, this channel shift was exacerbated by negative overall comps and negative low single digit store-only comps,” Gutman
said.
The analyst believes that while the consensus expectations assume comp growth, they ignore the market share growth among
competitors.
Although several discretionary product retailers seemed to have struggled in 1Q and due to the timing of Memorial Day, the
analyst believes that the market share shift was responsible for Bed Bath & Beyond’s comp weakness.
“Third, we still do not see a profit inflection. In-store and e-commerce investments are expected to continue and there is
heightened risk of margin pressure in light of weaker comps,” Gutman concluded.
Latest Ratings for BBBY
Date |
Firm |
Action |
From |
To |
Jun 2016 |
Credit Suisse |
Maintains |
|
Neutral |
Jun 2016 |
Goldman Sachs |
Maintains |
|
Sell |
Jun 2016 |
JP Morgan |
Maintains |
|
Neutral |
View More Analyst Ratings for
BBBY
View the Latest Analyst Ratings
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.